Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MaxART: The Effect of Early Access to ART for All in Swaziland on Economic Outcomes

NCT03789448 is registered in ClinicalTrials.gov with Till Bärnighausen as lead sponsor.

NCT NCT03789448
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03789448 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MaxART: The Effect of Early Access to ART for All in Swaziland on Economic Outcomes
Lead sponsor
Till Bärnighausen
Phase
Not applicable
Overall status
Completed
Start date
September 1, 2014
Completion date
August 31, 2017
Enrollment
3,019 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hiv/aids